Cancer type % methylation
B cell-Lymphoma(31) 20%
T cell-Lymphoma(31) 15%
MALT Lymphoma(31) 67%
AP-CML (32) 40%
Childhood B- ALL (33) 34.4%
Adult B- ALL (33) 26.7%
Multiple myeloma (34) 10%
Haematological malignancies (35) 10.9%
Acute Myeloid Leukemia (36) 0%
Acute Myeloid Leukemia (37) 83%
Acute Lymphoblastic leukemia (37) 85 %
Acute Lymphoblastic leukemia (36) 6%
Chronic lymphoblastic leukemia (38) 14.3%
present study (CML) 42%
Table 6: Frequency of P16INK4a methylation in different haematological malignancies.